These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34971322)

  • 21. Adjunctive Therapies to Optimize Closed-loop Glucose Control.
    Srinivasan S; Ekhlaspour L; Cengiz E
    J Diabetes Sci Technol; 2021 Nov; 15(6):1243-1251. PubMed ID: 34315267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.
    Jennings P; Hussain S
    J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in Care for Insulin-Requiring Patients Without Closed Loop.
    Lal RA; Buckingham B; Maahs DM
    Diabetes Technol Ther; 2018 Jun; 20(S2):S285-S291. PubMed ID: 29916743
    [No Abstract]   [Full Text] [Related]  

  • 24. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial.
    Haidar A; Legault L; Raffray M; Gouchie-Provencher N; Jacobs PG; El-Fathi A; Rutkowski J; Messier V; Rabasa-Lhoret R
    Diabetes Technol Ther; 2021 Mar; 23(3):168-174. PubMed ID: 33050728
    [No Abstract]   [Full Text] [Related]  

  • 27. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review on artificial pancreas and regenerative medicine used in the management of Type 1 diabetes mellitus.
    Sachdeva P; M AR; Shukla R; Sahani A
    J Med Eng Technol; 2022 Nov; 46(8):693-702. PubMed ID: 35801984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do-It-Yourself Artificial Pancreas System Use in Pregnant Women With Type 1 Diabetes in a Real-World Setting: 2 Case Reports.
    Lemieux P; Yamamoto JM; Donovan LE
    Can J Diabetes; 2021 Dec; 45(8):804-808.e2. PubMed ID: 33648862
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Based on Total Daily Insulin in Adolescents with Type 1 Diabetes.
    Schoelwer MJ; Robic JL; Gautier T; Fabris C; Carr K; Clancy-Oliveri M; Brown SA; Anderson SM; DeBoer MD; Cherñavvsky DR; Breton MD
    Diabetes Technol Ther; 2020 Aug; 22(8):594-601. PubMed ID: 32119790
    [No Abstract]   [Full Text] [Related]  

  • 31. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.
    Castellanos LE; Balliro CA; Sherwood JS; Jafri R; Hillard MA; Greaux E; Selagamsetty R; Zheng H; El-Khatib FH; Damiano ER; Russell SJ
    Diabetes Care; 2021 Jun; 44(6):e118-e120. PubMed ID: 33906916
    [No Abstract]   [Full Text] [Related]  

  • 34. Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial.
    Blauw H; Onvlee AJ; Klaassen M; van Bon AC; DeVries JH
    Diabetes Care; 2021 Mar; 44(3):836-838. PubMed ID: 33397767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.
    Herrero P; Bondia J; Adewuyi O; Pesl P; El-Sharkawy M; Reddy M; Toumazou C; Oliver N; Georgiou P
    Comput Methods Programs Biomed; 2017 Jul; 146():125-131. PubMed ID: 28688482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An In Silico Head-to-Head Comparison of the Do-It-Yourself Artificial Pancreas Loop and Bio-Inspired Artificial Pancreas Control Algorithms.
    Armiger R; Reddy M; Oliver NS; Georgiou P; Herrero P
    J Diabetes Sci Technol; 2022 Jan; 16(1):29-39. PubMed ID: 34861785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Closed-loop insulin delivery in type 1 diabetes.
    Thabit H; Hovorka R
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):105-17. PubMed ID: 22575409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.
    Kovatchev B; Cheng P; Anderson SM; Pinsker JE; Boscari F; Buckingham BA; Doyle FJ; Hood KK; Brown SA; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Ly TT; Shanmugham S; Dassau E; Kollman C; Lum JW; Beck RW
    Diabetes Technol Ther; 2017 Jan; 19(1):18-24. PubMed ID: 27982707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.